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Background: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a scavenger receptor, induced by oxidative stress, and suggested 
to be associated with atherosclerotic plaque destabilization. Soluble LOX-1 (sLOX-1) is known as a biomarker of acute coronary syndrome. It is 
reported that the LOX index, represented by multiplication of LOX-1 ligand containing apolipoprotein B (LAB) with sLOX-1, is associated with an 
increased risk of coronary artery disease and ischemic stroke. However, the role of sLOX-1 or LOX index as a cardiovascular risk marker in smokers is 
unknown. Therefore, we hypothesized that sLOX-1 and LOX index are related to smoking-related factors.
Method: We measured sLOX-1 and LAB levels in sera from 207 current smokers by ELISA.
Results: The sLOX-1 levels were positively correlated with smoking variables such as the number of cigarettes per day (r=0.150, p<0.05), expired 
air carbon monoxide (CO) concentrations (r=0.198, p<0.005), Fagerstrom test for nicotine dependence score (r=0.190, p<0.01), and serum high-
sensitivity C-reactive protein levels (hsCRP; r=0.232, p<0.005). The multivariate regression analysis revealed that the independent determinants 
of serum sLOX-1 levels were expired air CO concentrations (`=0.182, p<0.05) and hsCRP levels (`=0.213, p<0.01). LOX index were positively 
correlated with the number of cigarettes per day (r=0.188, p<0.01), Brinkman index (r=0.151, p<0.05), Fagerstrom test for nicotine dependence 
score (r=0.181, p<0.05), BMI (r=0.142, p<0.05), LDL-C (r=0.362, p<0.0001) and serum hsCRP (r=0.249, p<0.005). The multivariate regression 
analysis revealed that the independent determinants of LOX index were expired air CO concentrations (`=0.225, p<0.01), hsCRP levels (`=0.324, 
p<0.0005) and LDL-C (`=0.273, p<0.005).
Conclusions: Both the serum LOX-1 level and the LOX index are increased in close association with the expired air CO concentration, one of 
smoking-related indicators, and the hsCRP level, a representative inflammatory marker. Thus, LOX-1 may be up-regulated by smoking-induced 
inflammation at vessel walls, being involved in the increased risk of cardiovascular diseases.
